Shearman & Sterling advised Boston Scientific Corporation, as Borrower, on a second amendment to its existing $2.75 billion revolving credit facility, agented by Wells Fargo Bank, National Association. The amendment incorporates a new SOFR-based interest rate and extends the maturity of the facility. Proceeds from the facility are used to finance working capital and general corporate purposes.

Headquartered in Marlborough, Massachusetts, Boston Scientific Corporation develops, manufactures and markets medical devices for use in various interventional medical specialties worldwide.

The Team